Talphera (TLPH)

• Market cap: $59.7M
• 1 day: -9.22%
• 5 days: -1.54%
• 1 month: 16.36%
• 3 months: 217.62%
• 6 months: 134.86%
• Year to date: 116.91%
• 1 year: 43.92%
• 5 years: -96.5%
• 10 years: -98.68%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Employees: 13